Bayer Tumbles After Clinical Trial Failure, Roundup Case Loss
Wall Street Journal
Bayer fell around 20% after it stopped a late-stage study for a cardiovascular drug early due to lack of efficacy and was ordered to pay around $1.6 billion in a lawsuit relating to its Roundup weedkiller.